Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Should You Buy MediPharm Labs Stock Before its Earnings Report?

Should You Buy MediPharm Labs Stock Before its Earnings?MediPharm Labs Corp [stock_market_widget type=”inline” symbol=”MEDIF” template=”basic” color=”default”], the Canadian hemp stock, gained over 5% on June 15, 2020. This is on a rebound with net-zero returns since May 19, 2020. This hemp stock still has a negative year to date return at approximately 57%. MediPharm Labs stock is currently trading at CA$1.78 on the TSX with a market cap close to CA$233 million. Since February 2018, MediPharm Labs Corp hemp stock has increased 1.5x from its IPO price of CA$0.70. Should You Buy MediPharm Labs Stock Before its Earnings Report? Although the stock has gained value, we’re not convinced they’re worth a buy.

[stock_market_widget type=”chart” symbol=”MEDIF” chart=”line” range=”1y” interval=”1d” line-color=”rgb(0, 128, 0)”]

MediPharm secures CA$37 million through an institutional investor

Medipharm Hemp Stock

In a release dated June 8, MediPharm disclosed a successful closure of private placement with an institutional investor. The average gross process is valued at CA$37, 822,500. Half of these proceeds which are around CA$18.9 million pertains to unsecured convertible notes worth $20.5 million along with a warrant with rights to purchase 3.6 million common shares of this hemp stock.

The remaining half of the proceeds will be held in an escrow account as a subscription receipt. The company carried out an agreement with a licensed Canadian Trust company and appointed it as the subscription receipt agent.Algorithmic Stock Trades Cannabis Stocks

The portion of the gross proceeds held with the trust company will entitle the institutional investor to the same set of rights conferred by the realized half of the proceeds. The balance held in the escrow will be realized only after the satisfactory compliance of Escrow release conditions.

Through this fundraise, the company will have the financial flexibility to focus on its range of Cannabis 2.0 products. The company has also secured multiple global contracts for the supply of cannabis products. MediPharm’s processing capacity is currently close to 100,000 kilograms of dry cannabis flowers per year.

MediPharm upcoming Q1 2020 earnings release

Should You Buy MediPharm Labs Stock Before its Earnings Report?

In a press release on June 8, 2020, MediPharm announced that first-quarter 2020 earnings release is scheduled for June 18. The earnings results will be declared before the market opens for trading.

Analysts covering MediPharm expect sales in the March quarter to touch $23.74 million. This indicates year-over-year growth of 42.5%, up from $16.66 million in the prior-year period.

Similar to most marijuana stocks, MediPharm is also reporting a non-GAAP loss. Analysts expect the company’s earnings to fall to -$0.03 per share in 2020, compared to $0.01 in 2019. However, its profitability is expected to increase to $0.14 per share in 2021.

Investors can expect this hemp stock to gain momentum if it manages to beat estimates and provide strong guidance. It is valued at just 2x above sales and is well poised to outperform the broader markets in the second half of 2020. However, we are not convinced that this marijuana stock is a buy and we’ll need to wait to see how their current quarterly revenues shake out before recommending this pot stock.

Should You Buy MediPharm Labs Stock Before its Earnings Report?

About Cannin: Your Hemp Stock Investment Experts

About Cannin: Your Marijuana Stock Investment is your #1 resource for marijuana stock and hemp stock investment opportunities. Our global team of experts aggregates hundreds of hours of research and provide tips on the best hemp stock investments for 2020. We provide the latest hemp stock investment news and analysis. 

Use Cannin as your trusted resource for breaking cannabis and hemp investing news, featured cannabis and hemp company analysis, comprehensive cannabis and hemp stock reports, or get your free trial now. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest in cannabis.

Wall Street expects the cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in cannabis stocks is now. Interested in the best marijuana stocks for 2020? Interested in penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

Profit from the best hemp stocks – we’ll show you how at

Use the power of Algotrading to profit from stocks.

+25% Gains in 2019

+49.8% Gains in 2020

Backtested since 2012

We’re so confident you’ll love the predictive signals, we’re willing to give you a one-month risk-free trial to see it for yourself.